Ordin nr. 1301/500/2008 din 11 iulie 2008 Partea a ii-a

Tratamentul episodic sau supresiv al herpesului genital

recurent.

Herpes cutanat iniţial moderat/sever.

Tratamentul episodic sau supresiv al herpesului cutanat

recurent (forme moderate/severe).

Herpes zoster.

Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului.
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

J05AB01 ACICLOVIRUM CAPS. 200 mg

ACICLOVIR 200 mg 200 mg SLAVIA PHARM SRL

EUVIROX 200 mg 200 mg EUROPHARM SA

J05AB01 ACICLOVIRUM COMPR. 200 mg

ACICLOVIR 200 mg 200 mg TERAPIA SA

CLOVIRAL 200 mg 200 mg ANTIBIOTICE SA

ZOVIRAX 200 mg GLAXO WELLCOME FOUNDATION

LTD.
J05AB01 ACICLOVIRUM COMPR. DISP. 200 mg

ACICLOVIR 200 mg 200 mg OZONE LABORATORIES LTD.

LOVIR 200 mg 200 mg RANBAXY UK LIMITED
J05AB01 ACICLOVIRUM PULB. PT. SOL. INJ./ 250 mg

PERF.

VIROLEX 250 mg KRKA D.D. NOVO MESTO
J05AB01 ACICLOVIRUM CAPS. 400 mg

ACICLOVIR 400 mg 400 mg ARENA GROUP S.A.

J05AB01 ACICLOVIRUM COMPR. 400 mg

ACICLOVIR 400 mg 400 mg EGIS PHARMACEUTICALS

P.L.C.
J05AB01 ACICLOVIRUM COMPR. FILM. 400 mg

ACIKLOVIR 400 mg A & G MED TRADING S.R.L.

________________________________________________________________________________
______________________________________________________________________________

| 103 |L02BG01| AMINOGLUTETHIMIDUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

L02BG01 AMINOGLUTETHIMIDUM COMPR. 250 mg

ROGLUTEN(R) 250 mg 250 mg ACTAVIS S.R.L.

________________________________________________________________________________

______________________________________________________________________________

| 104 |M01AB01| INDOMETACINUM | |

|_______|_______|____________________________________________|_________________|
A se administra cu precauţie la pacienţii cu istoric de factori de risc sau afecţiuni gastrointestinale.
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

M01AB01 INDOMETACINUM SUPOZ. 50 mg

INDOMETACIN 50 mg 50 mg MAGISTRA C & C

________________________________________________________________________________

______________________________________________________________________________

| 105 |M01AB05| DICLOFENACUM | |

|_______|_______|____________________________________________|_________________|
A se administra cu precauţie la pacienţii cu istoric de factori de risc sau afecţiuni gastrointestinale.